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ABSTRACT
Ghrelin is an appetite-stimulating hormone produced mainly in the stomach and duodenum.
Poor ghrelin control is often caused by obesity-related hyperinsulinemia, which fails to suppress
ghrelin and results in excess appetite and higher body fat storage that perpetuates even greater fat
accumulation. High intensity exercise has been shown to acutely decrease plasma acylated
ghrelin concentrations in healthy weight individuals. However, the evidence for how exercise
affects ghrelin in obese individuals is currently lacking. PURPOSE: To compare the effects of
high intensity interval exercise on acute plasma acylated ghrelin levels in obese and non-obese
males. METHODS: Eighteen subjects with a mean age of 29.8 yr. (± 7.6) were assessed for
body fat percent (BF%), acylated ghrelin and hunger. Subjects included 9 non- obese men (BF%
mean= 13.7 ± 3.6) and 9 obese men (BF% mean = 31.7 ± 4.7) who agreed to participate in this
study. Using a crossover design, participants were randomly assigned to an exercise or control
condition, with each subject acting as their own control. The exercise trial consisted of
participants cycling at high intensity intervals for 20 minutes (not including the 5 minute warmup
and cool down) at a rate of 65% to 85% of their heart rate reserve on a cycle ergometer followed
by 60 minutes of rest. The control trial consisted of 90 minutes of rest. Blood samples (3-4ml)
were collected at baseline, 0.5, 1, and 1.5 hours post-intervention. Acylated ghrelin
concentrations were determined from plasma. Hunger was assessed using a 10-point Likert-type
scale while blood samples were being drawn. Group means for plasma ghrelin concentrations
between groups were analyzed using an independent t-test. The effect of exercise on ghrelin was
analyzed using paired t-test. The relationship between perceived hunger and ghrelin was
assessed using Pearson correlations. RESULTS: Baseline plasma ghrelin levels were
significantly higher in the non-obese group when compared to the obese group (t = 3.43, p =

.036). While exercise was effective in reducing plasma acylated ghrelin levels in the non-obese
group (t = 2.34, p = .047), no significant changes were found in acylated ghrelin in the obese
group between baseline or any time point following the exercise intervention. CONCLUSIONS:
The low resting levels of plasma ghrelin concentrations exhibited by the obese subjects, when
compared to non-obese subjects, may result in long fasting periods that lead to hypoglycemia
and a hyperinsulinemic response at the next eating opportunity. Furthermore, the lack of
reduction in ghrelin following exercise may result in an overconsumption of energy. Both the
sustained ghrelin with associated excess energy intake and the hyperinsulinemia may result in
sustained or increased fat storage in obese individuals.

INDEX WORDS: Ghrelin, Obesity, Exercise
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Effect of Acute High Intensity Interval Exercise and
Energy Balance on Plasma Acylated Ghrelin Concentrations
Chapter 1
Introduction
Worldwide obesity rates have nearly doubled since 1980 (43). In 2008, more than 1.4
billion adults, 20 years and older, were considered overweight. Of these, over 200 million men
and nearly 300 million women were obese (43). This creates a public health crisis as overweight
and obesity are leading risks for global premature deaths and disease. In addition to being a
severe health risk itself, being overweight or obese also increases the risk for cardiovascular
disease (coronary artery disease and stroke), diabetes, osteoarthritis, and cancers such as;
endometrial, breast and colon. Although the causes of overweight and obesity are multifaceted,
one of the primary factors is directly related to energy imbalance between calories consumed and
expended (43). This discrepancy in energy balance is associated with an increase in energy
intake and a concomitant decrease in physical activity (43). A report from the World Health
Organization points to a decrease in energy intake and an increase in physical activity as the two
primary alternatives that individuals can use to reduce bodyweight and begin to resolve the
epidemic of overweight and obesity (43).
Research completed over the last 15 years has discovered a number of potentially
important causes of the complex condition that is obesity. Ghrelin is one of several peptide
hormones secreted by the gastrointestinal tract and has received significant attention from the
research community as a potential target to regulate body weight (9, 19, 21, 41, 48).

After its

discovery as an endogenous ligand to the hypothalamic growth hormone (GH), researchers soon
found that exogenous administration of ghrelin in rodents increased food intake that caused fat
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and weight gain. This effect of ghrelin has highlighted its role in weight regulation (19, 41, 47,
53).
Ghrelin is synthesized as a preprohormone, which is proteolytically processed to a 28
amino acid peptide (3, 28). Ghrelin circulates in both venous and arterial blood in two different
forms: acylated (or n-octanoylated, AG) and unacylated (or des-octanoylated or des-acylated,
UAG or dAG) (31, 47). AG uniquely features a posttranslational esterification of a fatty acid on
the serine residue at position 3. Ghrelin acylation is considered necessary for its actions as an
endogenous ligand to the growth-hormone secretagogue receptor (GHSR) in which it stimulates
the release of growth hormone (GH). Under homeostatic conditions, AG accounts for
approximately 10% of total circulating ghrelin. Although UAG does not affect GH release, it is
not biologically inactive. For example, UAG binds to other unknown receptors and have effects
that are inconclusive in the research (27, 47).
Ghrelin is secreted mostly by stomach fundus, but also by the placenta, and in small
amounts by the kidney, the pituitary and the hypothalamus (53). Ghrelin’s ability to regulate
appetite is independent of its role in GH stimulation (19). Research suggests that the
hypothalamic hormones neuropeptide Y (NPY) and agouti growth-related peptide (AGRP) are
intermediaries to the orexigenic effects of ghrelin. In these animal studies, the administration of
ghrelin caused an increase in hypothalamic NPY and AGRP mRNA levels and the orexigenic
effect was maintained even in mice that lacked NPY (19).
In addition, ghrelin has been shown to activate growth hormone secretagogue receptors
(GHSRs) located on the pituitary and GH releasing hormone (GHRH) containing neurons in the
hypothalamic arcuate nucleus, which stimulate GH release. In parallel, the activation of GHSRs
by ghrelin on NPY/AGRP producing neurons located in the arcuate nucleus stimulates food
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intake. Ghrelin increases fat tissue by decreasing fat oxidation and stimulates gastric motility
and emptying (41). Studies on rodents and humans have established ghrelin as a food intake
initiator and as a regulator of energy homeostasis (18, 52). Also, it is the first discovered food
intake stimulating signal secreted by the stomach (41).
In adults, plasma ghrelin concentrations have been shown to increase prior to a meal and
during fasting and to decrease within one hour after a meal no matter the macronutrient content.
Ghrelin levels are increased under conditions of prolonged negative energy balance (i.e., low
calorie diets, chronic exercise and/or anorexia nervosa) (41). In contrast, under obese conditions
(chronic positive energy balance), pre-prandial ghrelin concentrations are typically low when
compared to non-obese subjects. This trend in low pre-prandial ghrelin concentrations may be
related to an over consumption of energy by this population, that results in excessive adipose
deposits. However, a reduction in body weight in obese patients has been shown to result in an
increase in ghrelin concentration (60).
During the past decade, the effect of exercise on ghrelin and energy intake has been
studied extensively. Research to date has been inconclusive; however there is evidence
suggesting that in non-obese populations, concentrations of plasma acylated ghrelin are
suppressed after strenuous endurance exercise (55, 57), while concentrations of anorexigenic
hormones (i.e., GLP-1, PYY, and PP) are increased (48) (see figure 1). These alterations in
plasma ghrelin concentrations are shown to have a linear relationship with appetite at rest (as
assessed using subjective visual analogue scales for feelings such as hunger, fullness, satisfaction
and prospective food consumption) and may provide a potential mechanism for alterations of
appetite or food and beverage intake post-exercise (5, 8, 22).
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Unfortunately, published studies on this topic have differed in mode, intensity and/or duration of
exercise making it difficult to define an advantageous form of exercise that will decrease plasma
acylated ghrelin levels. In the majority of studies that have used non-obese subjects of both
genders, with similar mode, duration and intensity the results indicate a reduction in plasma
acylated ghrelin levels following exercise (48). In contrast, the results of the few studies that
have attempted to compare the effects of acute exercise on plasma ghrelin levels in obese
subjects remain inconclusive (26, 37). Research that compares these two populations have yet to
come to a consensus on the mode, duration and intensity that is most viable for overweight and
obese populations. Because individuals who are obese may not be accustomed to exercise,
research done on this population should include exercises that match intensity, mode and
duration of exercise with the physical capabilities of members of this group. Furthermore,
exercise prescription for this population should be set to a level that is safe and attainable for
their fitness level. Therefore, it is important to investigate the relationship between an acute bout
of short-term high intensity interval training on plasma ghrelin concentrations in a population of
healthy weight and obese males. Based on the efficacy of strenuous exercise to decrease plasma
acylated ghrelin levels and increase anorexigenic hormones, we hypothesize that the intermittent
high intensity bouts of exercise, performed in set time intervals will be effective in reducing
acylated ghrelin levels in obese subjects to the same degree as healthy weight subjects.
Ghrelin and Energy Balance
The balancing of energy intake and expenditure involves multiple, complex systems. For
example, when considering energy intake; the meal size, meal frequency, diet quality, and net
absorption should be quantified. In addition, energy expenditure involves the consideration of
several variables, including diet quality, metabolism, physical activity, meal frequency, and the
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thermic effect of food (4). Once all of these factors are considered, the impact of ghrelin and
other peptide hormones must also be taken into account.
Short term studies have highlighted ghrelin’s role in energy balance. In rodents,
exogenous ghrelin has been shown to signal meal initiation and cause a significant and dose
related increase in cumulative food intake in rats (49). In humans, ghrelin levels are increased in
response to a short-term fast and then decrease post-prandially (21). Ghrelin’s role as a longterm regulator of energy balance and weight regulation is highlighted by the fact that plasma
ghrelin levels fluctuate up and down in response to energy expenditure and intake, respectively.
However, studies have shown that this action of ghrelin may be unique to lean subjects; it seems
that obese subjects do not experience this same reduction in plasma ghrelin in response to
feeding (44, 50), which may result in an over consumption of energy. This dysregulation of
ghrelin production may, in part, contribute to weight gain in the obese population (19). The
observation that ghrelin is further decreased in cases of abnormally high energy intake is
evidence to the relationship between ghrelin activity and energy balance in obese subjects (38).
Ghrelin and Growth Hormone
Growth Hormone is a peptide hormone secreted from the anterior pituitary gland that
stimulates overall body and cell reproduction and regeneration. Research has shown that GH
release is regulated by two mechanisms: it is stimulated by hypothalamic GHRH and it is
inhibited by somatostatin (32). However, recent research has revealed that ghrelin also activates
the release of GH by binding to GHSRs (32).
Specifically, ghrelin stimulates GH release from primary pituitary cells in a dosedependent manner by traveling through the bloodstream from the stomach to the pituitary (32).
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Furthermore, intravenous injection of ghrelin induces potent GH release 5-15 minutes after
injection before returning to basal levels approximately one hour later (13).
Although ghrelin has been found to stimulate both GH secretion and appetite, ones action
is not dependent on the other. For example, the exogenous administration of ghrelin caused an
increase in food intake in growth hormone-deficient spontaneous dwarf rats, suggesting that the
feeding behavior function of ghrelin is independent of its GH stimulating function (49). These
findings suggest that ghrelin acts on a site other than the GHSR to exert its affect as an appetite
enhancer. This distinction is important if the blockade of ghrelin is to be used therapeutically to
reduce body fat and weight. Because ghrelin stimulates GH the use of an antagonist to block its
effects might have an adverse impact on growth and therefore, should not be used. However,
because the effect of ghrelin on feeding have been found to be unrelated to its impact on GH
secretion, research that focuses on locating the receptor that it interacts with to initiate appetite
will go a long way in determining ghrelin’s efficacy as a weight loss therapy.
Effect of Ghrelin on Glucose and Insulin
Ghrelin is also expressed in the β-cells of the pancreas (10, 14, 23, 56, 58) suggesting a
possible relationship with insulin. Insulin is released from β-cells in the pancreas in response to
high plasma glucose concentrations. It regulates the metabolism of carbohydrates and fats by
promoting the absorption of glucose from the blood to skeletal muscles and fat tissue and by
causing fat to be stored rather than used for energy. The first indications that there was an
interaction between ghrelin and glucose metabolism resulted from the discovery that
subcutaneous ghrelin injections induced an increase of the respiratory quotient (RQ). To
researchers, the augmented utilization of carbohydrate and reduced utilization of fat to meet
energy requirements was consistent with the observed increase in body fat (52). Numerous other

7

studies since 2000 have suggested that ghrelin has an important role in modulating β-cell
function and glucose homeostasis (15, 34, 39, 40).
Many studies have investigated the short-term and long-term effects of ghrelin; however,
effects on glucose and insulin homeostasis are still being debated. When administered acutely
ghrelin induced hyperglycemia and reduced insulin secretion in healthy weight, healthy humans
(6). In contrast, when the experiments were carried out in obese patients, there were no
differences in glucose or insulin levels following ghrelin administration (1). Other studies have
concluded that prolonged ghrelin infusion lowered insulin sensitivity (45). Together these
results suggest that the short-term effects of ghrelin induce hyperglycemia, hypoinsulinemia, and
insulin resistance in healthy, healthy weight humans. Yet, Heppner et al. (27) found that central
infusion of AG and dAG increased insulin in the presence of glucose. In this study the effect of
either type of ghrelin isoform caused glucose stimulated hyperinsulinemia when administered
intracerebroventricularly. However, AG and dAG are blunted and nullified, respectively, when
delivered subcutaneously (27). This demonstrates that the GHSR in the central nervous system
play a critical role in insulin handling.
Blockade of ghrelin significantly lowers fasting glucose concentrations and enhances the
insulin response (17). In obese, insulin resistant rodents, Esler et al. (20) found that short-term
blockade of endogenous ghrelin had no noticeable effect on insulin sensitivity but did improve
glucose tolerance by stimulating insulin secretion. However, ghrelin was blocked for several
days in the same population of mice and plasma glucose levels diminished. This reduction in
glucose levels was accompanied by a moderate decrease in serum insulin levels, suggesting that
the insulin resistance was improved in the long-term (2). The data obtained in this research
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suggests that acute and chronic reductions in ghrelin may improve glucose tolerance and
improve insulin resistance in obese, insulin resistant populations.
Ghrelin and Adiposity
Ghrelin has been found to be produced in the region of the brain involved in the control
of energy balance (11). Studies have found that peripheral and central administration of ghrelin
caused weight and fat gain by reducing fat utilization. For example, Heppner et al. (27) found
that central administration of both AG and dAG increased adiposity. AG reduced locomotor
activity (LA) and increased the respiratory exchange ratio (RER) (as measured by direct
calorimetry). However, when AG and dAG were injected peripherally the increase in adiposity
was blunted and ablated, respectively. Both AG and dAG increased feeding, but the effect of
increased adiposity was maintained even when feeding was not increased. The increase in fat
mass in response to ghrelin injections is somewhat surprising when considering the lipolytic
effect of GH, yet the appetite stimulating effect of ghrelin has been found to be independent of
its effect on GH secretion (53). An increase in energy intake in mice might be the primary cause
of an increase in adiposity in response to an elevation in plasma ghrelin concentrations. Wren et
al. (59) observed that ghrelin administered either centrally or peripherally, dramatically increased
food intake in rats exposed to ad libitum feeding. Shintani et al. (49) concluded that ghrelin
reversed the leptin-induced inhibition of food intake and decreased the hypothalamic
neuropeptide Y expression. NPY is thought to cause leptin’s satiety effect. This might suggest
that ghrelin is an antagonist to leptin (42). Other research suggests that the orexigenic potency of
ghrelin is caused by the activation of hypothalamic NPY and Y1 receptors along with a
subsequent increase in gastric emptying (3). This finding has challenged research that contends
that the most important hypothalamic target of ghrelin is AGRP (29).
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Studies have shown a dramatic pre-prandial rise and postprandial fall in circulating
ghrelin levels, thereby substantiating ghrelin as a physiological meal initiator (12). Research has
also found that obese subjects have lower plasma ghrelin concentrations than that of agematched, lean controls. It has been suggested that chronic positive energy balance in the obese
population may cause a down-regulation of plasma ghrelin concentrations. Although ghrelin has
been shown to increase body weight and fat, its role in human obesity has been challenged.
Studies that utilized clamped energy balance conditions suggest that ghrelin was not related to
the magnitude of body weight changes in either overfeeding or negative energy balance (46).
Taken together the data from the research completed on ghrelin and adiposity suggests
that it may increase adiposity, by increasing feeding, decreasing LA and increasing RER.
However, there has yet to be any understanding of the mechanisms that reduce plasma ghrelin
concentrations in the obese and increase it under extreme low body weight conditions.
Nevertheless, ghrelin’s role as a regulator of energy balance has been hypothesized, such that it
is secreted in times of negative energy balance to signal the hypothalamus when an increase in
metabolic efficiency is needed and is not secreted during times of positive energy balance as to
prevent the consumption of additional energy.
Effect of Macronutrients on Ghrelin
Research has shown that digestion of protein, carbohydrates and fat effect plasma ghrelin
levels in different capacities. In studies completed on healthy weight subjects the results suggest
that protein has the greatest impact on long-term satiety and lowering of plasma ghrelin
concentrations. Foster-Schubert et al. (21) used isoenergy; isovolemic beverages composed
primarily of carbohydrates, proteins or lipids as their intervention and found that protein had the
highest magnitude of ghrelin suppression followed by carbohydrates and lipids. Although
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carbohydrates had the fastest ghrelin lowering effect, three hours after ingestion ghrelin levels
rose above pre-prandial values. Data from a study investigating the correlations between
macronutrient intake and human brain and gut hormone responses concluded that although there
were no differences in brain responses when the diverse macronutrients were consumed, ghrelin
levels were decreased to a higher degree in response to protein consumption when compared to
carbohydrates and fats (35). These data suggest that in healthy weight individuals, protein is the
optimal macronutrient for long term satiety and lower ghrelin levels. However, the same is not
true for obese individuals.
It has been well documented that body mass index (BMI), body fat and indices of central
fat distribution are inversely associated with fasting plasma ghrelin concentrations (33). Positive
energy balance observed in obese individuals may suppress maximal circulating ghrelin to limit
energy consumption. The impaired cholinergic (vagal) regulation of postprandial drop in ghrelin
concentrations might be also responsible for the dysregulated ghrelin control in obese subjects
(36). Although obese subjects have low pre-prandial ghrelin levels their postprandial ghrelin
secretion is not sufficiently suppressed to reduce appetite, which causes continued hunger after a
meal (33). In a study on ghrelin responses to high fat and high protein iso-energy meals in a
group of obese women, Pavlatos et al. (44) determined that neither macronutrient elicited a
significant acute ghrelin response. In support of these findings, Tentolouris et al. (50) reported
that a high carbohydrate meal was also incapable of inducing a decrease in postprandial ghrelin
levels in a group of obese women. In addition, leaner individuals had higher fasting ghrelin
levels and faster declines of postprandial ghrelin. It seems, then, that leaner people feel hungrier
before a meal but become satiated faster than an obese individual. Some factors that may
explain the blunted postprandial response in obese subjects might be the impaired post-meal
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elevation of gastrointestinal hormones with anorexigenic and insulinomimetic properties, such as
glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and
peptide YY (PYY) (24). Taken together, the data from these experiments show a vast difference
exists in the ability of an obese individual to secret and uptake ghrelin when compared to a
healthy weight individual.
Effect of Acute Exercise on Ghrelin
Evidence has suggested that concentrations of plasma acylated ghrelin are suppressed
after strenuous endurance exercise in non-obese, healthy subjects. Reductions in ghrelin levels
have been detected along with a concomitant decrease in appetite at rest and may provide a
potential mechanism for alterations of appetite or food beverage intake post-exercise (5, 8, 22),
especially in obese populations.
Past studies related to the effects of exercise on plasma ghrelin levels have utilized a
variety of modes, intensities and durations of exercise. Typically, moderate to vigorous cycling
or running at intensities ranging from 50% to 75% of maximal oxygen uptake (𝑉̇ O2max) and
lasting approximately one hour have been used (21). In a study completed by Vatansever-Ozen
et al. (55), 10 healthy male subjects ran for 105 minutes at an intensity of 50% of 𝑉̇ O2max and 15
minutes at 70% of 𝑉̇ O2max (for a total of 120 minutes). The results of this study concluded that
this mode and intensity of exercise caused a reduction in AG levels that correlated with a
reduction in appetite. In contrast to these findings, data from Burns et al. (9) suggests that an
acute bout of treadmill running has no effect on total plasma ghrelin levels. The differences in
the findings may result from the fact that one study measured AG and the other measured total
ghrelin. It is still being debated whether or not dAG has the same effects on the human body as
AG. Some studies suggest that AG and dAG have different actions (48), while others have
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found that they exhibit similar effects on adiposity and glucose homeostasis (27). The fact that
Burns et al. (9) used both males and females in their subject pool may have also altered their
results as differences between appetite and energy intake may be dissimilar between males and
females. Hagobian and colleagues (25) evaluated sex differences in hormones and energy intake
in response to control conditions with four days of exercise with energy replacement (to maintain
energy balance) and four days of exercise without energy replacement (energy deficit). In
response to a meal tolerance test after four days in balance or deficit, women had markedly
higher AG concentrations compared with baseline, while no significant difference existed in
men.
Although some of the research investigating the effects of exercise on plasma ghrelin
concentrations has utilized obese female and male subjects (26, 37, 51, 54), most research has
been centered on healthy weight females and males (5, 7, 8, 9, 16, 23, 30, 37, 55, 57). Research
involving obese subjects is lacking therefore there is no agreement in the literature in regards to
an appropriate mode, duration or intensity of exercise that may be beneficial in reducing plasma
ghrelin levels in this population. Furthermore, the issue on whether acute exercise impacts
ghrelin levels in this population is still inconclusive. Using a population of overweight women,
Tiryaki-Sonmez et al. (51) found that an acute bout of running at an intensity of 50% of 𝑉̇ O2max
significantly reduced AG levels in this group. An earlier study concluded that walking at an
intensity of 70% to 75% of age-predicted maximal heart rate elicited no effect on plasma AG
(54). Many differences in methodology could account for the difference in results between these
experiments. In the group that observed a change, the subjects were younger and although they
were overweight they were not obese, as were the group of women in which no significant
difference was found. Also, the intensity of exercise was more appropriately defined in the
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group for which exercise significantly reduced AG. Exercise using age predicted maximal heart
rate does not take the fitness level of the participant into account; therefore the exercise may not
produce the desired result. Because these studies utilized female subjects, the question exists
whether or not these results would be the same using a male population with similar body
compositions.
In addition to the studies on obese individuals as a whole lacking in the scientific
literature, research comparing healthy weight to obese individuals (using the same mode,
duration and intensity of exercise) are almost void in the literature. The research that does exist
either utilizes a mixture of males and females at a moderate intensity and duration (26) or they
do not provide the distribution of the population used nor the duration or intensity of exercise
(37). It would be very difficult to extrapolate meaningful interventions from these data.
Summary
The research on ghrelin is conclusive on its role to regulate energy balance by stimulating
feeding during times of negative energy balance and decreasing feeding during times of positive
energy balance. In addition, research has shown that plasma ghrelin levels are reduced postprandially faster in healthy weight than in the overweight or obese. Increases in plasma ghrelin
concentrations have also been associated with reductions in fat metabolism. These mechanisms
might contribute to preventing weight gain in healthy weight individuals and stimulate additional
weight gain in the overweight or obese. Thus, interventions that target ghrelin might aid in
weight reduction in overweight or obese populations. Exercise has been proposed as one method
of modulating ghrelin levels in these individuals. Many forms of acute endurance exercise have
been shown to reduce plasma AG concentrations in healthy weight individuals. These reductions
in AG levels have been observed with a concomitant decrease in appetite and increase in the
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secretion of anorexigenic hormones (i.e., GLP-1, PYY, and PP) (see figure 2). However, the
effect of exercise on plasma ghrelin levels and anorexigenic hormones in the obese is
inconclusive. The research studies that have been completed on this topic have differed in their
results, mode, intensity and duration of exercise. Also, studies have failed to investigate an
intensity of exercise that is feasible for this population.
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Effect of Acute High Intensity Interval Exercise and
Energy Balance on Plasma Acylated Ghrelin Concentrations
Chapter 2
Obesity has become a public health crisis that is a leading risk factor for global premature
deaths and disease. Although the causes of obesity are multifaceted, one of the primary factors
is directly related to energy imbalance between calories consumed and expended (22). This
discrepancy in energy balance is associated with an increase in energy intake and a concomitant
decrease in physical activity (22). The report from the World Health Organization points to a
decrease in energy intake and an increase in physical activity as the two primary alternatives that
individuals can use to reduce body fat and begin to resolve the epidemic of obesity.
Research completed over the last 15 years has discovered a number of potentially
important causes of the complex condition that is obesity. Ghrelin is one of several peptide
hormones secreted by the gastrointestinal tract and has received significant attention from the
research community as a potential target to regulate body weight (5, 8, 9, 20, 25). After its
discovery as an endogenous ligand to the hypothalamic growth hormone (GH), researchers soon
found that exogenous administration of ghrelin in rodents increased food intake and caused fat
and weight gain. This effect of ghrelin has highlighted its role in weight regulation (8, 20, 24,
30).
Ghrelin is synthesized as a preprohormone, which is proteolytically processed to a 28
amino acid peptide (1, 15). Ghrelin circulates in both venous and arterial blood in two different
forms: acylated (or n-octanoylated, AG) and unacylated (or des-octanoylated or des-acylated,
UAG or dAG) (18, 24). AG uniquely features a posttranslational esterification of a fatty acid on
the serine residue at position 3. Ghrelin acylation is considered necessary for its actions as an
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endogenous ligand to the growth-hormone secretagogue receptor (GHSR) in which it stimulates
the release of growth hormone (GH). Under homeostatic conditions, AG accounts for
approximately 10% of total circulating ghrelin. Although UAG does not affect GH release, it is
not biologically inactive. For example, UAG binds to other unknown receptors and have effects
that are inconclusive in the research (11, 24).
Ghrelin is secreted mostly by stomach fundus, but also by the placenta, and in small
amounts by the kidney, the pituitary and the hypothalamus (30). Ghrelin’s ability to regulate
feeding is independent of its role in GH stimulation (8). Research suggests that the hypothalamic
hormones neuropeptide Y (NPY) and agouti growth-related peptide (AGRP) are intermediaries
to the orexigenic effects of ghrelin. In these animal studies, the administration of ghrelin caused
an increase in hypothalamic NPY and AGRP mRNA levels and the orexigenic effect was
maintained even in mice that lacked NPY (8).
In adults, plasma ghrelin concentrations have been shown to increase prior to a meal and
during fasting and to decrease within one hour after a meal no matter the macronutrient content.
Ghrelin levels are increased under conditions of prolonged negative energy balance (i.e., low
calorie diets, chronic exercise and/or anorexia nervosa) (20). In contrast, under obese conditions
(chronic positive energy balance), ghrelin concentrations are typically low, which may be related
to energy consumption patterns that result in excessive adipose deposits, whereas a reduction in
body weight in obese patients results in an increase in ghrelin concentration (34).
During the past decade, the effect of exercise on ghrelin and energy intake has been
studied extensively. Research to date has been inconclusive; however there is evidence
suggesting that in non-obese populations, concentrations of plasma acylated ghrelin are
suppressed after strenuous endurance exercise (32, 33), while concentrations of anorexigenic
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hormones (i.e., GLP-1, PYY, and PP) are increased (25) (see figure 1). These alterations in
plasma ghrelin concentrations are shown to have a linear relationship with appetite at rest (as
assessed using subjective visual analogue scales for feelings such as hunger, fullness, satisfaction
and prospective food consumption) and may provide a potential mechanism for alterations of
appetite or food and beverage intake post-exercise (2, 3, 10).
The purpose of this study was to investigate the effect of a bout of short-term high
intensity interval exercise on plasma acylated ghrelin (AG) levels in obese men when compared
to non-obese men. Although the exercise method includes high intensity exercise the intensity
was defined by each individual’s pre-calculated heart rate reserve. The duration of each bout of
high intensity exercise was 20 minutes not including the warm up and cool down period, after
which the participant dismounted the cycle and rested in the seated position until having blood
drawn. Based on the efficacy of moderate to vigorous exercise to decrease plasma ghrelin levels,
we hypothesized that high intensity interval exercise would be effective in acutely reducing
acylated ghrelin levels in obese subjects. However, the degree to which ghrelin concentrations
are reduced will be significantly less in the obese group than in a non-obese group. This research
project is designed to answer the question marks in figure 2.
Methods
Participants
All procedures were approved by the Georgia State University Institutional Review
Board (IRB). Eighteen healthy men (9 obese and 9 non-obese) aged 28.9 ± 7.6 years
participated in this study. Participants signed a written informed consent that detailed all of the
procedures and risks involved in the experiment. The participants completed a health screen and
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physical activity questionnaire (Appendix A). All participants were non-smokers, not on a
weight gain or weight loss diet at the time of the experiment and had not been on any such diet in
the previous six months leading up to participation in the experiment. Each individual
maintained a stable bodyweight (had not lost or gained more than 10% of their bodyweight) in
the previous six months, had no gastric or digestive problems, no known history of
cardiovascular disease, including: diabetes, stroke or heart attack and had a resting arterial blood
pressure <140/90 mmHg. To gauge whether or not a prospective participant had incurred a
weight change of 10% or more in the six months leading up to the experiment, they were asked,
“if their clothing sizes had changed in the six months leading up to the experiment”.
Preliminary Tests
Anthropometry
Height was measured to the nearest .25 cm using a standard wall stadiometer. Body mass
was measured to the nearest 0.1 kg using a standard digital weighing scale (Tanita, WB – 110A
Class III, USA). Fat mass and lean mass was determined using Dual-energy X-ray
absorptiometry (DEXA) (GE Lunar Prodigy Primo Bone Densitometer).
𝑽̇O2max test
Between 5-7 days prior to initiation of the experimental protocol, 𝑉̇ O2max was determined
on a cycle ergometer (Velotron RaceMate CompuTrainer, USA) using a standard testing
protocol in accordance with ACSM guidelines (22). All participants began the 𝑉̇ O2max testing
with a 5 minute warm up. After the warm up participants cycled at a preset resistance of 75
watts. The resistance was then increased every 2 minutes by 25 watts until the participant could
no longer continue or until 𝑉̇ O2 began to decline. At the 2 minute mark participants were asked
to rate their exertion using a Borg rate of perceived exertion scale while their heart rate and 𝑉̇ O2
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were assessed. Oxygen consumption (𝑉̇ O2) and carbon dioxide production (𝑉̇ CO2) were
measured throughout the entire exercise session using a True One 2400 metabolic measurement
system (PAR Medics, Sandy, Utah, USA) which is a computer controlled breath-by-breath
analyzer. The participants 𝑉̇ O2max was defined as the highest value for (𝑉̇ O2) achieved during
the exercise test. The attainment of a valid 𝑉̇ O2max required that participants met the following
criteria: a final respiratory exchange ratio (RER) > 1.0, (𝑉̇ O2) consumption increased by < 2
ml·kg-1·min-1 with an increase in exercise intensity and with attainment of >85% of agepredicted maximal heart rate and or voluntary termination of the test by the participant.
Heart Rate (HR) was measured continuously throughout the test using a commercially
available Polar HR monitor (S610i Polar Electron, Finland). Typically the test was terminated
when subjects demonstrated that they could longer continue with the maximum workload or if
the participant’s oxygen utilization failed to increase with an increase in exercise intensity or
began to decline. Participants were allowed a 5 minute cool down period after the test was
terminated.
Experimental Protocol and Main Trials
Subjects visited the laboratory on three separate occasions. All participants performed the
𝑉̇ O2max test on their initial visit. After the 𝑉̇ O2max test participants were randomly assigned to a
control or experimental trial. Two main trials (exercise and control) were performed in a
counterbalanced, randomized design. The interval between the two trials was at least three days.
In addition, participants were allowed to begin one of the trial conditions three days after the
𝑉̇ O2max test was completed. This was done to allow time for each participant to track two days of
feeding and physical activity before each trial. For each trial the participants reported to the
laboratory after a 10-hour overnight fast. Upon arrival participants were allowed to rest in a
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seated position for 10 to 15 minutes, after which an intravenous catheter was inserted into an
antecubital vein. During this period, participants were asked to rate their hunger using a hunger
scale (described below). During the control experiment, the participants continued to rest
(reading, working quietly, or watching television) for approximately two hours. During the
exercise trial, the participants cycled on a cycle ergometer for 30 minutes (including a five
minute warmup and five minute cool down) and then rested for one and a half hours (see Table
1). The exercise trial consisted of 20 minutes of high intensity interval exercise on a cycle
ergometer at 65%-85% of heart rate reserve (HRR). Subjects were allowed a 5 minute warmup
period after which subjects were allowed 30 seconds to attain a heart rate of 85% of their HRR
and had to maintain that pace for 30 seconds. After 30 seconds, subjects were allowed a one
minute active recovery period in which subjects pedaled at a reduced pace to allow their
heartrate to drop to 65% of HRR (this counted as one repetition). If during the active recovery
period the subject’s heart rate dropped below 65% of HRR before the 1- minute recovery period
had elapsed they were required to reconvene the working phase of exercise.
Blood samples (~3 mL) were drawn into chilled tubes containing 1.25mg·ml-1 Na2EDTA
and 500 TIU·ml-1 aprotinin (Kallikrein Inhibitor Unit), Phoenix, Burlingame, USA at baseline,
and at 0.5, 1 and 1.5 hours after baseline for the determination of acylated ghrelin. All samples
were drawn by a licensed registered nurse. Participants were in a seated position for at least five
minutes before blood was withdrawn. Water was available ad libitum during both trials and
participants were encouraged to drink at least 20 ounces before reporting to the laboratory to
assure that blood volume was sufficient. Hunger was assessed at each blood sampling point.

32

Table 1. Shows the activities of each subject on both exercise and control days.
Exercise
Resting
Variable

Hunger Rating

40 Minutes

40 Minutes

Insert catheter

Insert catheter

Blood draw

Blood draw

X

Blood draw

Blood draw

X

Blood draw

Blood draw

X

Blood draw

Blood draw

X

Prep
25 Minutes
Baseline
10 Minutes
Post Exercise
30 minutes
Post Exercise
1 hour
Post Exercise
1.5 hours
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Dietary Protocol and Energy Balance
Participants were asked to maintain their normal dietary and physical activity programs
throughout the duration of the study. Subjects were also asked to refrain from physical exercise,
alcohol and caffeine for 24 hours before testing. Because energy balance and macronutrient
intake can influence plasma ghrelin levels, participants were asked to consume precisely the
same diet for two days prior to control and testing day. In the 48 hours prior to testing,
individuals were asked to record an hour-by-hour account of all physical activity performed over
resting levels and provide a detailed description of all food and beverage types consumed and the
amount (see Appendix B). This information was used to determine each individual’s energy
balance. Energy balance was determined using NutriTiming® (NutriTiming LLC). Subjects
were advised to consume their last meal at least 10 hours prior to each experimental trial.
Hunger Scale
The hunger scores were determined using the satiety and hunger scale developed by
Burgoon (see Appendix C) (25). Participants indicated their perceived level of hunger by
circling the number that best represented how hungry they felt. The following phrases were
included in the scale: “famished, starving”, “not hungry, not full”, and “bursting, painfully full”.
Blood samples and hormone analysis
Blood samples were drawn by a licensed registered nurse via a catheter (Insyte™
Autoguard™) inserted into the antecubital vein of each subject. Blood was drawn into 3ml
lithium heparin tubes (B-D Vacutainer). Immediately after collecting blood samples, the sample
tubes were centrifuged (GS-6KR Centrifuge, Beckman Coulter) at 2002 x g for 15 minutes at
4°C AG. The obtained plasma samples were immediately aliquoted into 20μl tubes and stored at
–80°C until assayed. Plasma acylated ghrelin assay was performed using a commercially
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available ELISA (EIA-A05106; Biotech Centre, SPI Bio & Ellipse Pharmaceuticals; Bertin
Pharma, Montigny le Bretonneux, France) with a detection limit of 1.5 pg · ml-1.
Statistical Analysis
Statistical analysis was performed using IBM SPSS Statistics 20. Descriptive statistics
were used to report the statistics of the two samples, obese and non-obese subjects. Independent
samples t-test were used to assess between group differences in baseline acylated ghrelin levels,
𝑉̇ O2max, HR and work rate. Repeated-measures, two-factor ANOVA was used to examine
differences between the two trials and over four timed occasions for acylated ghrelin and to
measure within group differences at each time point. Where significant main and interaction
effects were found, post-hoc analysis was performed using Bonferroni correction for multiple
comparisons. Pearson correlation was used to determine the relationship between energy
balance, hunger and ghrelin between trials and within the two groups across the timed occasions.
Data were presented as appropriate with statistical significance set at p < 0.05.
Results
Exercise Protocol and Testing
The non-obese group’s 𝑉̇ O2max was statistically significantly higher than that of the obese
group (p = .004) (Table 2). Also, the max HR and work rate achieved by the non-obese group
was significantly higher than the obese group (p = .045 and .005, respectively) (Table 2).
Although there were no significant differences found between the groups in relation to max HR
achieved during the exercise protocol and the duration of the exercise protocol, the non-obese
absolute force output during the interval exercise was significantly higher than the obese group
(p = .007). Rate of perceived exertion did not differ between the groups.
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Plasma-acylated ghrelin concentrations
Independent samples t-test revealed a statistically significant difference in acylated
ghrelin levels between the groups at baseline (p = .004) and 90 minutes post exercise (p = .036)
(Figure 3) during the control trial with the non-obese group having higher acylated ghrelin levels
than the obese group at both time points. However, no significant differences were found
between the groups at any time point during the exercise trial (Figure 4).
Repeated measures ANOVA showed a statistically significant difference in acylated
ghrelin in the non-obese group between baseline and 90 minutes (p = .024). No differences were
found within the obese group at any time point during the control trial (Figure 5 and 6). Analysis
during the exercise trial revealed a significant difference in the non-obese group across the four
time intervals. Pairwise comparisons indicate that the significant differences occurred between
baseline and 30 minutes (p = .047) and 30 minutes and 90 minutes (p = .011) (Figure 7). In the
non-obese group plasma-acylated ghrelin concentrations declined sharply after exercise but rose
to near baseline levels 60 minutes post-exercise. No significant differences were found between
any time intervals for the obese group (Figure 8).
Plasma-acylated ghrelin and hunger
Independent samples t-test revealed no differences between groups in perceived hunger
ratings at any time interval during either trial. Pearson correlations revealed no relationships
between plasma-acylated ghrelin levels and hunger perceptions in either group or trial.
Plasma-acylated ghrelin and energy balance
Pearson Correlations revealed a positive relationship between hours spent in an optimal
energy balance (OEB = +/- 400 kcal) range and baseline plasma-acylated ghrelin concentrations
(r = .89, p = .003) (hours spent in OEB = 12.89 ± 4.3) in the obese group. No relationships were
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Table 2. Participant Descriptive Data

Variable
Age (Years)
Height (m)
Body Fat (%)
Weight (kg)
BMI
Fat Mass (kg)
Lean Mass (kg)
VO2Max
VO2Max(L/min)
Max HR
Max Watt
RPE
IT Max HR
IT Max Watt
IT Stage
Optimal EB
(hr ± 400kcal)
EB hr > 400 (kcal)
Above EB
EB hr < -400(kcal)
Below EB

Non-Obese
N=9
𝑋 ± SD
26.1 ± 5.4
1.82 ± 0.08
13.7 ± 3.6
87.7 ± 14.8
26.2 ± 3.0
11.8 ± 4.6
72.0 ± 10.4
47.6 ± 9.6
4.1 ± 0.74
185.9 ± 14.9
277.8 ± 47.5
18.4 ± 1.7
173.1 ± 9.7
277.8 ± 44.1
12.7 ± 1.6

Obese
N=9
𝑋 ± SD
31.7 ± 8.8
1.77 ± 0.05
31.7 ± 4.7
100.1 ± 11.6
31.8 ± 3.8
30.5 ± 6.7
65.2 ± 7.4
30.7 ± 6.6
3.0 ± 0.59
172.4 ± 10.8
216.7 ± 17.7
18.2 ± 2.4
167.3 ± 5.9
225.0 ± 17.7
11.44 ± 1.0

13.6 ± 6.1

12.89 ± 4.3

.79

.11 ± .33

2.33 ± 4.0

.14

10.33 ± 6.2

8.78 ± 5.7

.57

Probability
.127
.123
.000**
.067
.003*
.000**
.131
.001*
.004*
.045*
.005*
.827
.152
.007*
.072

Values are represented as mean ± SD
*P < 0.05, **P < 0.01 indicate significant difference between groups
BMI - Body Mass Index (Ht-cm2/Wt-kg), VO2Max – Maximal Oxygen Consumption, Maximal HR – Max Heart Rate,
RPE – Rate of Perceived Exertion, IT Maximal HR – Interval Training Max Heart Rate, IT Max Watt – Interval Training
Maximal Wattage, IT Stage – Interval stages completed
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found between plasma-acylated ghrelin and any of the energy balance variables in the non-obese
group.
Discussion
The purpose of this study was to investigate the relationship between an acute bout of
short-term high intensity interval training on plasma ghrelin concentrations in a population of
obese and non-obese males. The primary findings are that during the control trial significant
differences were found between the two groups at baseline and 90 minutes. Furthermore, while
high intensity interval exercise did not have the impact of reducing acylated ghrelin in the obese
group, it was effective in reducing this hormone in the non-obese group. Although acylated
ghrelin levels decreased significantly post-exercise, it rebounded back to near baseline levels 60
minutes post-exercise. Despite not being significantly reduced in the obese group, acylated
ghrelin levels exhibited a trend towards decline during the post exercise assessments in this
population and continued this downward trend throughout the period of analysis.
The finding that baseline ghrelin levels were higher in the non-obese groups is consistent
with research that suggests that acylated ghrelin levels are depressed in obese individuals when
compared to non-obese subjects (1). However, such changes in ghrelin do not appear to reduce
appetite or result in reduction in weight in this population (6). Our findings that plasma acylated
ghrelin was decreased post exercise in the non-obese group is consistent with the findings of
other research completed on this topic (2, 4, 7, 13, 16, 19, 32, 33). Burns et al. (5) assessed the
effects of treadmill exercise on total ghrelin and found no significant change, however these
findings cannot be compared to the findings of the current research because only acylated ghrelin
was measured in this study. Other research has found that while exercise was effective in
reducing acylated ghrelin, total ghrelin levels remained the same (19, 31).
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The results of this experiment determined that exercise was ineffective in reducing
acylated ghrelin levels in the obese group. While these findings are consistent with other
research completed on this topic (13, 31), it must be understood that the difference in the current
research is that only males were assessed, in the previous two studies both male and female were
used (13) or a female only (31) population. Previous research has demonstrated that there are
sex related differences in acylated ghrelin and energy intake in response to exercise (11). In
conflict with the findings of our data, other research studies found that exercise was effective in
reducing AG in obese populations (19, 28).
However, in contrast to our experimental protocol, these research studies used an
exhaustive form of exercise that could not be used in a clinical setting to facilitate weight loss in
a deconditioned, obese population. Furthermore, one of these studies (19) did not specify an
average time of exercise nor did they affirm whether or not the population was all male or mixed.
These omissions make it impossible to determine whether or not the findings of these two
experiments are comparable.
The finding that plasma ghrelin levels were significantly reduced from baseline compared
to 90 minutes was unanticipated due to the fact that the subjects remained in a fasted state
throughout the entire evaluation period. Although subjects were permitted to drink water ad
libitum, research studies using animal (21) and human (26) models have shown no significant
effect of water on plasma ghrelin concentrations. Because no other hormones were assessed it is
impossible to make a causative assumption about why the anomaly occurred.
Our findings revealed a correlation between hunger and AG 30 minutes post-exercise in
the non-obese group, however no correlation between plasma acylated ghrelin concentrations
and hunger were found at any other time point after exercise or during control.
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No correlation was found at any time point, during either protocol in the obese group. This was a
surprise due to the overwhelming evidence in the literature that support the link between the two
(3, 4, 7, 16, 31, 32, 33). However, it must also be understood that ghrelin is only one component
of the appetite-regulating neuroendocrine system and that appetite is most likely impacted by
other hormonal and physiological elements (17). Still, these findings add to the discussion of
whether or not acylated ghrelin can be used as a physiological element of appetite. An answer
may come through the utilization of specific ghrelin antagonists in clinical investigations.
A positive correlation was observed between hours spent in optimal energy balance and
plasma acylated ghrelin in the obese population. This is a novel finding due to the fact that to the
authors’ knowledge there is no known published research that has identified a link between hours
spent in optimal energy balance and acylated ghrelin in obese individuals. However, research
has determined that no differences existed in post-exercise AG levels when exercise resulted in
an energy deficit compared to when energy balance was maintained (11). This finding may be
evidence that in addition to weight loss, the dysregulation of ghrelin observed in this population
may be counterbalanced by adequately matching energy expenditure with energy intake.
One limitation of this study was the sample size. Several control plasma samples where
lost due to hemolysis of the samples during both protocols. Although this may have affected the
samples taking on the day of control it did not have an impact on the non-obese exercise trial.
Most samples taken during the exercise protocol were usable samples. No non-obese subjects
had to be removed from the exercise data. In addition, the hunger scale used in this experiment
was a limitation. The scale did not provide a robust enough range to allow participants to
accurately detail their hunger perceptions. Due to this fact the mean range for hunger ratings
was 2, meaning all ratings were between 3 and 5. Therefore, although significance was found at
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one time point the trend for the two variables was not similar. The average rating of hunger
found at baseline was similar to all other time points, consequently the significance found
between these two variables could be attributed to chance and not to an actual relationship.
Conclusions
In conclusion, this is the first study to investigate the effects of a safe and appropriate
form of exercise for use in a sedentary, obese population for the purposes of weight loss and
plasma acylated ghrelin measurement and to compare the effects of energy balance on this
gastric hormone in an obese and non-obese male population. Exercise had the effect of reducing
acylated ghrelin levels in the non-obese subjects; however it did not have this impact on the
obese group. Furthermore, baseline ghrelin levels were lower in the obese group when compared
to the non-obese group. Lastly, hours spent in optimal energy balance were positively correlated
to plasma acylated ghrelin in the obese population and no correlation was found in the non-obese
population. Although the form of exercise used in this experiment was not effective in reducing
ghrelin levels or the perception of hunger, it also did not result in an increase in either parameter.
This outcome is a positive one for all clinicians that are responsible for designing weight loss
plans for overweight and obese individual. Future studies should compare the effects of high
intensity interval exercise on insulin, leptin, and peptide YY on this population and go further to
compare these changes in a population of obese and non-obese females.
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Table 3. Control Day Ghrelin Levels
Descriptive Statistics

Group
Non-Obese

ConBL
Con30

Mean

Std. Deviation

N

12.63748

3.412720

5

8.64730

2.185062

5

10.57973

5.662090

5

9.69067

2.076221

5

7.50721

3.497867

6

7.23335

2.488228

6

7.69245

3.152897

6

7.96552

1.514791

6

Con60

Obese

Con90
ConBL
Con30
Con60
Con90

Values are represented as mean ± SD
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Table 4. Exercise Day Ghrelin Levels
Descriptive Statistics

Group
Non-Obese

Mean
ExBL

Std.
Deviation

N

14.63738

6.127499

9

10.11546

4.211545

9

13.28626

8.775724

9

14.27690

7.111714

9

10.65790

4.182061

6

8.73105

3.339732

6

9.09747

3.109702

6

8.57359
Values are represented as mean ± SD

1.768613

6

Ex30
Ex60

Obese

Ex90
ExBL
Ex30
Ex60
Ex90
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